Download PDF
Endoscopy 2021; 53(12): 1261-1273
DOI: 10.1055/a-1671-6336
Guideline

Endoscopic tissue sampling – Part 2: Lower gastrointestinal tract. European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Roos E. Pouw
 1   Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Cancer Center Amsterdam, Amsterdam University Medical Centers location VUmc, Amsterdam, The Netherlands
,
Raf Bisschops 
 2   Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium
,
Krisztina B. Gecse
 3   Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers location AMC, Amsterdam, The Netherlands
,
Gert de Hertogh
 4   Department of Pathology, University Hospitals Leuven, Leuven, Belgium
,
Marietta Iacucci
 5   Institute of Translational Medicine, Institute of Immunology and Immunotherapy and NIHR Birmingham Biomedical Research Centre, University Hospitals NHS Foundation Trust and University of Birmingham, Birmingham, UK
,
Matthew Rutter 
 6   Department of Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, UK
,
Maximilien Barret
 7   Department of Gastroenterology and Digestive Oncology, Cochin Hospital and University of Paris, Paris, France
,
Katharina Biermann
 8   Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands
,
László Czakó
 9   First Department of Medicine, University of Szeged, Szeged, Hungary
,
Tomas Hucl
10   Institute for Clinical and Experimental Medicine, Prague, Czech Republic
,
Marnix Jansen
11   Department of Histopathology, University College London Hospital, London, UK
,
Edoardo Savarino 
12   Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
,
Manon C. W. Spaander 
13   Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands
,
Peter T. Schmidt
14   Department of Medicine (Solna), Karolinska Institute and Department of Medicine, Ersta Hospital, Stockholm, Sweden
,
Mário Dinis-Ribeiro
15   Department of Gastroenterology, Portuguese Oncology Institute of Porto, Porto, Portugal
,
Michael Vieth
16   Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Klinikum Bayreuth, Bayreuth, Germany
,
Jeanin E. van Hooft 
17   Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Recommendations

1 ESGE suggests performing segmental biopsies (at least two from each segment), which should be placed in different specimen containers (ileum, cecum, ascending, transverse, descending, and sigmoid colon, and rectum) in patients with clinical and endoscopic signs of colitis.

Weak recommendation, low quality of evidence.

2 ESGE recommends taking two biopsies from the right hemicolon (ascending and transverse colon) and, in a separate container, two biopsies from the left hemicolon (descending and sigmoid colon) when microscopic colitis is suspected.

Strong recommendation, low quality of evidence.

3 ESGE recommends pancolonic dye-based chromoendoscopy or virtual chromoendoscopy with targeted biopsies of any visible lesions during surveillance endoscopy in patients with inflammatory bowel disease.

Strong recommendation, moderate quality of evidence.

4 ESGE suggests that, in high risk patients with a history of colonic neoplasia, tubular-appearing colon, strictures, ongoing therapy-refractory inflammation, or primary sclerosing cholangitis, chromoendoscopy with targeted biopsies can be combined with four-quadrant non-targeted biopsies every 10 cm along the colon.

Weak recommendation, low quality of evidence.

5 ESGE recommends that, if pouch surveillance for dysplasia is performed, visible abnormalities should be biopsied, with at least two biopsies systematically taken from each of the afferent ileal loop, the efferent blind loop, the pouch, and the anorectal cuff.

Strong recommendation, low quality of evidence.

6 ESGE recommends that, in patients with known ulcerative colitis and endoscopic signs of inflammation, at least two biopsies be obtained from the worst affected areas for the assessment of activity or the presence of cytomegalovirus; for those with no evident endoscopic signs of inflammation, advanced imaging technologies may be useful in identifying areas for targeted biopsies to assess histologic remission if this would have therapeutic consequences.

Strong recommendation, low quality of evidence.

7 ESGE suggests not biopsying endoscopically visible inflammation or normal-appearing mucosa to assess disease activity in known Crohn’s disease.

Weak recommendation, low quality of evidence.

8 ESGE recommends that adequately assessed colorectal polyps that are judged to be premalignant should be fully excised rather than biopsied.

Strong recommendation, low quality of evidence.

9 ESGE recommends that, where endoscopically feasible, potentially malignant colorectal polyps should be excised en bloc rather than being biopsied. If the endoscopist cannot confidently perform en bloc excision at that time, careful representative images (rather than biopsies) should be taken of the potential focus of cancer, and the patient should be rescheduled or referred to an expert center.

Strong recommendation, low quality of evidence.

10 ESGE recommends that, in malignant lesions not amenable to endoscopic excision owing to deep invasion, six carefully targeted biopsies should be taken from the potential focus of cancer.

Strong recommendation, low quality of evidence.

Table 1 s



Publication History

Received: 15 October 2021

Accepted after revision: 18 October 2021

Article published online:
29 October 2021

© 2021. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Pouw RE, Barret M, Biermann K. et al. Endoscopic tissue sampling – Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2021; DOI: 10.1055/a-1611-5091.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490
    CrossrefPubMedGoogle Scholar
  • 3 Dumonceau JM, Hassan C, Riphaus A. et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline Development Policy. Endoscopy 2012; 44: 626-629
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Dejaco C, Oesterreicher C, Angelberger S. et al. Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis. Endoscopy 2003; 35: 1004-1008
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Annese V, Daperno M, Rutter MD. et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013; 7: 982-1018
    CrossrefPubMedGoogle Scholar
  • 6 Yantiss RK, Odze RD. Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract. Am J Gastroenterol 2009; 104; 774-783
    PubMedGoogle Scholar
  • 7 Langner C, Aust D, Ensari A. et al. Histology of microscopic colitis – review with a practical approach for pathologists. Histopathology 2015; 66: 613-626
    CrossrefPubMedGoogle Scholar
  • 8 Nguyen GC, Smalley WE, Vege SS. et al. American Gastroenterological Association Institute Guideline on the medical management of microscopic colitis. Gastroenterol 2016; 150: 242-246
    CrossrefPubMedGoogle Scholar
  • 9 Arasaradnam RP, Brown S, Forbes A. et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut 2018; 67: 1380-1399
    CrossrefPubMedGoogle Scholar
  • 10 Münch A, Sanders DS, Molloy-Bland M. et al. Undiagnosed microscopic colitis: a hidden cause of chronic diarrhea and a frequently missed treatment opportunity. Frontline Gastroenterol 2019; 11: 228-234
    CrossrefPubMedGoogle Scholar
  • 11 Kanstrup Fiehn AM, Heiberg Engel PJ, Lanzarotto F. et al. Topographical distribution of microscopic colitis and the importance of orientation of paraffin-embedded biopsies. Human Pathol 2020; 103: 63-71
    CrossrefPubMedGoogle Scholar
  • 12 Kanstrup Fiehn AM, Miehlke S, Aust D. et al. Distribution of histopathological features along the colon in microscopic colitis. Int J Colorectal Dis 2021; 36: 151-159
    CrossrefPubMedGoogle Scholar
  • 13 Seenarain V, Idrees M, Mogridge J. et al. Random colonic biopsies in macroscopically normal colonoscopies: is there any benefit? A two-centre audit of current practice.. ANZ J Surg 2020; 90: E163-E167
    CrossrefPubMedGoogle Scholar
  • 14 Miehlke S, Guagnozzi D, Zabana Y. et al. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterol J 2021; 9: 13-37
    CrossrefPubMedGoogle Scholar
  • 15 Annese V, Daperno M, Rutter MD. et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013; 7: 982-1018
    CrossrefPubMedGoogle Scholar
  • 16 Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012; 10: 639-645
    CrossrefPubMedGoogle Scholar
  • 17 Rutter MD, Saunders BP, Wilkinson KH. et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004; 53: 1813-1816
    CrossrefPubMedGoogle Scholar
  • 18 Rutter MD, Saunders BP, Wilkinson KH. et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterol 2006; 130: 1030-1038
    CrossrefPubMedGoogle Scholar
  • 19 Mahmoud R, Shah SC, Ten Hove JR. et al. No association between pseudopolyps and colorectal neoplasia in patients with inflammatory bowel diseases. Gastroenterol 2019; 156: 1333-1344
    CrossrefPubMedGoogle Scholar
  • 20 Barclay RL, Vicari JJ, Doughty AS. et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. NEJM 2006; 355: 2533-2541
    CrossrefPubMedGoogle Scholar
  • 21 Subramanian V, Ramappa V, Telakis E. et al. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 350-355
    CrossrefPubMedGoogle Scholar
  • 22 Subramanian V, Mannath J, Ragunath K. et al. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33: 304-312
    CrossrefPubMedGoogle Scholar
  • 23 van den Broek FJ, Stokkers PC, Reitsma JB. et al. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences. Am J Gastroenterol 2014; 109: 715-722
    CrossrefPubMedGoogle Scholar
  • 24 Imperatore N, Castiglione F, Testa A. et al. Augmented endoscopy for surveillance of colonic inflammatory bowel disease: systematic review with network meta-analysis. J Crohns Colitis 2019; 13: 714-724
    CrossrefPubMedGoogle Scholar
  • 25 Yang DH, Park SJ, Kim HS. et al. High-definition chromoendoscopy versus high-definition white light colonoscopy for neoplasia surveillance in ulcerative colitis: a randomized controlled trial. Am J Gastroenterol 2019; 114: 1642-1648
    CrossrefPubMedGoogle Scholar
  • 26 Iacucci M, Kaplan GG, Panaccione R. et al. A randomized trial comparing high definition colonoscopy alone with high definition dye spraying and electronic virtual chromoendoscopy for detection of colonic neoplastic lesions during IBD surveillance colonoscopy. Am J Gastroenterol 2018; 113: 225-234
    CrossrefPubMedGoogle Scholar
  • 27 Feuerstein JD, Rakowsky S, Sattler L. et al. Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer. Gastrointest Endosc 2019; 90: 186-195
    CrossrefPubMedGoogle Scholar
  • 28 Moussata D, Allez M, Cazals-Hatem D. et al. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?. Gut 2018; 67: 616-624
    PubMedGoogle Scholar
  • 29 Kandiah K, Subramaniam S, Thayalasekaran S. et al. Multicentre randomised controlled trial on virtual chromoendoscopy in the detection of neoplasia during colitis surveillance high-definition colonoscopy (the VIRTUOSO trial). Gut 2021; 70: 1684-1690
    CrossrefPubMedGoogle Scholar
  • 30 Hu AB, Burke KE, Kochar B. et al. Yield of random biopsies during colonoscopies in inflammatory bowel disease patients undergoing dysplasia surveillance. Inflamm Bowel Dis 2021; 27: 779-786
    CrossrefPubMedGoogle Scholar
  • 31 Torres C, Antonioli D, Odze RD. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. Am J Surg Pathol 1998; 22: 275-284
    CrossrefPubMedGoogle Scholar
  • 32 Krugliak Cleveland N, Huo D, Sadiq F. et al. Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease. Gastrointest Endosc 2018; 87: 1304-1309
    CrossrefPubMedGoogle Scholar
  • 33 Ten Hove JR, Mooiweer E, Dekker E. et al. Low rate of dysplasia detection in mucosa surrounding dysplastic lesions in patients undergoing surveillance for inflammatory bowel diseases. Clin Gastroenterol Hepatol 2017; 15: 222-228
    CrossrefPubMedGoogle Scholar
  • 34 Lahiff C, Wang LM, Travis SPL. et al. Diagnostic yield of dysplasia in polyp-adjacent biopsies for patients with inflammatory bowel disease: a cross-sectional study. J Crohns Colitis 2018; 12: 670-676
    CrossrefPubMedGoogle Scholar
  • 35 Lamb CA, Kennedy NA, Raine T. et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019; 68: s1-s106
    CrossrefPubMedGoogle Scholar
  • 36 Annese V, Beaugerie L, Egan L. et al. European evidence-based consensus: inflammatory bowel disease and malignancies. J Crohns Colitis 2015; 9: 945-965
    CrossrefPubMedGoogle Scholar
  • 37 Kariv R, Remzi FH, Lian L. et al. Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy. Gastroenterol 2010; 139: 806-812
    CrossrefPubMedGoogle Scholar
  • 38 Derikx LAAP, Kievit W, Drenth JPH. et al. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease. Gastroenterol 2014; 146: 119-128
    CrossrefPubMedGoogle Scholar
  • 39 Scarpa M, van Koperen PJ, Ubbink DT. et al. Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis. Br J Surg 2007; 94: 534-545
    CrossrefPubMedGoogle Scholar
  • 40 Kuiper T, Vlug MS, van den Broek FJ. et al. The prevalence of dysplasia in the ileoanal pouch following restorative proctocolectomy for ulcerative colitis with associated dysplasia. Colorectal Dis 2012; 14: 469-473
    CrossrefPubMedGoogle Scholar
  • 41 Zhao-Xiu L, Ming-Bing X, Xian-Rui W. et al. Chronic pouchitis is associated with pouch polyp formation in patients with underlying ulcerative colitis. J Crohns Colitis 2014; 8: 363-369
    CrossrefPubMedGoogle Scholar
  • 42 Vento P, Lepistö A, Kärkkäinen P. et al. Risk of cancer in patients with chronic pouchitis after restorative proctocolectomy for ulcerative colitis. Colorectal Dis 2011; 13: 58-66
    CrossrefPubMedGoogle Scholar
  • 43 Zhu H, Wu XR, Queener E. et al. Chronic pouchitis is associated with pouch polyp formation in patients with underlying ulcerative colitis. J Crohns Colitis 2014; 8: 363-369
    CrossrefPubMedGoogle Scholar
  • 44 Herline AJ, Meisinger LL, Rusin LC. et al. Is routine pouch surveillance for dysplasia indicated for ileoanal pouches?. Dis Colon Rectum 2003; 46: 156-159
    CrossrefPubMedGoogle Scholar
  • 45 Nilubol N, Scherl E, Bub DS. et al. Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy. Dis Colon Rectum 2007; 50: 825-831
    CrossrefPubMedGoogle Scholar
  • 46 Bryant RV, Burger DC, Delo J. et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut 2016; 65: 408-414
    CrossrefPubMedGoogle Scholar
  • 47 Lemmens B, Arijs I, van Assche G. et al. Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis. Inflamm Bowel Dis 2013; 19: 1194-1201
    CrossrefPubMedGoogle Scholar
  • 48 Simsek HD, Basyigit S, Aktas B. et al. Assessment of the correlation between endoscopic activity and histological activity in ulcerative colitis patients. Med Princ Pract 2016; 25: 378-384
    CrossrefPubMedGoogle Scholar
  • 49 Iacucci M, Fort Gasia M, Hassan C. et al. Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings. Endoscopy 2015; 47: 726-734
    Article in Thieme ConnectPubMedGoogle Scholar
  • 50 Iacucci M, Kiesslich R, Gui X. et al. Beyond white light: optical enhancement in conjunction with magnification colonoscopy for the assessment of mucosal healing in ulcerative colitis. Endoscopy 2017; 49: 553-559
    Article in Thieme ConnectPubMedGoogle Scholar
  • 51 Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C. et al. Development and validation of the Nancy histological index for UC. Gut 2017; 66: 43-49
    CrossrefPubMedGoogle Scholar
  • 52 Mosli MH, Feagan BG, Zou G. et al. Development and validation of a histological index for UC. Gut 2017; 66: 50-58
    CrossrefPubMedGoogle Scholar
  • 53 Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. NEJM 1987; 317: 1625-1629
    CrossrefPubMedGoogle Scholar
  • 54 Travis SP, Schnell D, Krzeski P. et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 2012; 61: 535-542
    CrossrefPubMedGoogle Scholar
  • 55 Osterman MT, Scott FI, Fogt FF. et al. Endoscopic and histological assessment, correlation, and relapse in clinically quiescent ulcerative colitis (MARQUEE). Inflamm Bowel Dis 2021; 27: 207-214
    CrossrefPubMedGoogle Scholar
  • 56 Iacucci M, Daperno M, Lazarev M. et al. Development and reliability of the new endoscopic virtual chromoendoscopy score: the PICaSSO (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis. Gastrointest Endosc 2017; 86: 1118-1127
    CrossrefPubMedGoogle Scholar
  • 57 Iacucci M, Smith SCL, Bazarova A. et al. An international multicenter real-life prospective study of electronic chromoendoscopy score PICaSSO in ulcerative colitis. Gastroenterology 2021; 160: 1558-1569.e8
    CrossrefPubMedGoogle Scholar
  • 58 Novak G, Parker CE, Pai RK. et al. Histologic scoring indices for evaluation of disease activity in Crohn's disease. Cochrane Database Syst Rev 2017; 7: CD012351
    PubMedGoogle Scholar
  • 59 Novak G, Stevens T, van Viegen T. et al. Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn’s disease. Aliment Pharmacol Ther 2019; 49: 1401-1409
    CrossrefPubMedGoogle Scholar
  • 60 Dragasevic S, Sokic-Milutinovic A, Stojkovic Lalosevic M. et al. Correlation of patient-reported outcome (PRO-2) with endoscopic and histological features in ulcerative colitis and Crohn's disease patients. Gastroenterol Res Pract 2020; 2020: 2065383
    CrossrefPubMedGoogle Scholar
  • 61 Molander P, Sipponen T, Kemppainen H. et al. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD. J Crohns Colitis 2013; 7: 730-735
    CrossrefPubMedGoogle Scholar
  • 62 Tajra JB, Calegaro JU, de Paula AP. et al. Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn's disease under treatment. Gastroenterol 2019; 54: 441-445
    PubMedGoogle Scholar
  • 63 Gong W, Guo K, Zheng T. et al. Correlation between endoscopic and histological validated scoring indices in Crohn's disease. Dig Liver Dis 2019; 51: 812-817
    CrossrefPubMedGoogle Scholar
  • 64 Geboes K, Rutgeerts P, Opdenakker G. et al. Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn’s disease. Curr Med Res Opin 2005; 21: 1741-1754
    CrossrefPubMedGoogle Scholar
  • 65 Sipponen T, Kärkkäinen P, Savilahti E. et al. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings. Aliment Pharmacol Ther 2008; 28: 1221-1229
    CrossrefPubMedGoogle Scholar
  • 66 Lang-Schwarz C, Angeloni M, Agaimy A. et al. Validation of the ‘Inflammatory Bowel Disease–Distribution, Chronicity, Activity (IBD-DCA) Score’ for ulcerative colitis and Crohn’s disease. J Crohns Colitis 2021; 15: 1621-1630
    CrossrefPubMedGoogle Scholar
  • 67 Brennan GT, Melton SD, Spechler SJ. et al. Clinical implications of histologic abnormalities in ileocolonic biopsies of patients with Crohn's disease in remission. J Clin Gastroenterol 2017; 51: 43-48
    CrossrefPubMedGoogle Scholar
  • 68 Bateman AC, Patel P. Lower gastrointestinal endoscopy: guidance on indications for biopsy. Frontline Gastroenterol 2014; 5: 96-102
    CrossrefPubMedGoogle Scholar
  • 69 Bisschops R, East JE, Hassan C. et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2019. Endoscopy 2019; 51: 1155-1179
    Article in Thieme ConnectPubMedGoogle Scholar
  • 70 Komeda Y, Kashida H, Sakurai T. et al. Magnifying narrow band imaging (NBI) for the diagnosis of localized colorectal lesions using the Japan NBI Expert Team (JNET) classification. Oncology 2017; 93: 49-54
    CrossrefPubMedGoogle Scholar
  • 71 Hewett DG, Kaltenbach T, Sano Y. et al. Validation of a simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterol 2012; 143: 599-607
    CrossrefPubMedGoogle Scholar
  • 72 Rutter MD, Chattree A, Barbour JA. et al. British Society of Gastroenterology/Association of Coloproctologists of Great Britain and Ireland guidelines for the management of large non-pedunculated colorectal polyps. Gut 2015; 64: 1847-1873
    CrossrefPubMedGoogle Scholar
  • 73 Cho SB, Park SY, Yoon KW. et al. [The effect of post-biopsy scar on the submucosal elevation for endoscopic resection of rectal carcinoids]. Korean J Gastroenterol 2009; 53: 36-42
    PubMedGoogle Scholar
  • 74 Han KS, Sohn DK, Choi DH. et al. Prolongation of the period between biopsy and EMR can influence the nonlifting sign in endoscopically resectable colorectal cancers. Gastrointest Endosc 2008; 67: 97-102
    CrossrefPubMedGoogle Scholar
  • 75 Chen CH, Wu KL, Hu ML. et al. Is a biopsy necessary for colon polyps suitable for polypectomy when performing a colonoscopy?. Chang Gung Med J 2011; 34: 506-511
    PubMedGoogle Scholar
  • 76 Absar MS, Haboubi NY. Colonic neoplastic polyps: biopsy is not efficient to exclude malignancy. The Trafford experience. Tech Coloproctol 2004; 8: s257-s260
    CrossrefPubMedGoogle Scholar
  • 77 Gondal G, Grotmol T, Hofstad B. et al. Biopsy of colorectal polyps is not adequate for grading of neoplasia. Endoscopy 2005; 37: 1193-1197
    Article in Thieme ConnectPubMedGoogle Scholar
  • 78 Sung HY, Cheung DY, Cho SH. et al. Polyps in the gastrointestinal tract: discrepancy between endoscopic forceps biopsies and resected specimens. Eur J Gastroenterol Hepatol 2009; 21: 190-195
    CrossrefPubMedGoogle Scholar
  • 79 Blumberg D. Laparoscopic colon resection of benign polyps: high grade dysplasia on endoscopic biopsy and polyp location predict risk of cancer. Surg Laparosc Endosc Percutan Tech 2009; 19: 255-257
    CrossrefPubMedGoogle Scholar
  • 80 Marshall JB, Diaz-Arias AA, Barthel JS. et al. Prospective evaluation of optimal number of biopsy specimens and brush cytology in the diagnosis of cancer of the colorectum. Am J Gastroenterol 1993; 88: 1352-1354
    PubMedGoogle Scholar
  • 81 Choi Y, Choi HS, Jeon WK. et al. Optimal number of endoscopic biopsies in diagnosis of advanced gastric and colorectal cancer. J Korean Med Sci 2012; 27: 36-39
    CrossrefPubMedGoogle Scholar
  • 82 Gado A, Ebeid B, Abdelmohsen A. et al. Improving the yield of histological sampling in patients with suspected colorectal cancer during colonoscopy by introducing a colonoscopy quality assurance program. Gastroenterology Res 2011; 4: 157-161
    PubMedGoogle Scholar
  • 83 Backes Y, Seerden TCJ, van Gestel R. et al. Tumor seeding during colonoscopy as a possible cause for metachronous colorectal cancer. Gastroenterol 2019; 157: 1222-1232
    CrossrefPubMedGoogle Scholar
  • 84 Hassan C, Ponchon T, Bisschops R. et al. European Society of Gastrointestinal Endoscopy (ESGE) Publications Policy – Update 2020. Endoscopy 2020; 52: 123-126
    Article in Thieme ConnectPubMedGoogle Scholar